Avastin Can Cause RPLS and Nasal Septum Perforation

Lee Coleman

Contributor

0 CommentsPrint ArticleSubscribe

The FDA and Genetech notified healthcare professionals about revisions to the warnings and adverse reaction sections of the prescribing information on Avastin about cases of a rare brain-capillary leak syndrome called (RPLS) reversible posterior leukoencephalopathy syndrome and reports of nasal septum perforation.

"RPLS is a neurological disorder associated with hypertension, fluid retention and cytotoxic effects of immunosuppressive drugs on the vascular endothelium. The syndrome can present with headache, seizure, lethargy, confusion, blindness and other visual and neurologic disturbances. Mild to severe hypertension may be present, but is not necessary for diagnosis. The onset of symptoms has been reported to occur from 16 hours to 1 year after initiation of Avastin. Magnetic Resonance Imaging (MRI) is necessary to confirm the diagnosis of RPLS."

Continue reading "Avastin Can Cause RPLS and Nasal Septum Perforation"